IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIUSTINA, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.677
AS - Asia 9.659
EU - Europa 7.780
SA - Sud America 1.752
Continente sconosciuto - Info sul continente non disponibili 308
AF - Africa 211
OC - Oceania 24
Totale 45.411
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.220
CN - Cina 3.527
SG - Singapore 3.147
UA - Ucraina 2.592
BR - Brasile 1.438
HK - Hong Kong 1.201
DE - Germania 1.064
PL - Polonia 781
FR - Francia 723
FI - Finlandia 622
VN - Vietnam 537
GB - Regno Unito 484
IT - Italia 475
RU - Federazione Russa 381
TR - Turchia 378
IE - Irlanda 373
IN - India 293
CA - Canada 240
BD - Bangladesh 152
AR - Argentina 94
MX - Messico 73
ZA - Sudafrica 70
IQ - Iraq 60
SE - Svezia 56
EC - Ecuador 54
ID - Indonesia 49
JP - Giappone 44
ES - Italia 41
CO - Colombia 39
NL - Olanda 38
NG - Nigeria 37
PK - Pakistan 35
PY - Paraguay 35
SA - Arabia Saudita 35
JM - Giamaica 32
BE - Belgio 28
CL - Cile 28
MA - Marocco 28
VE - Venezuela 28
CZ - Repubblica Ceca 27
IR - Iran 25
PE - Perù 23
UZ - Uzbekistan 23
AE - Emirati Arabi Uniti 22
AU - Australia 22
IL - Israele 21
EU - Europa 20
CR - Costa Rica 18
AT - Austria 17
TT - Trinidad e Tobago 15
NP - Nepal 14
HN - Honduras 13
KE - Kenya 13
JO - Giordania 12
AZ - Azerbaigian 11
GT - Guatemala 11
MY - Malesia 11
SV - El Salvador 11
PT - Portogallo 10
EE - Estonia 9
EG - Egitto 9
GP - Guadalupe 9
KZ - Kazakistan 9
LT - Lituania 9
NI - Nicaragua 9
DZ - Algeria 8
ET - Etiopia 8
KR - Corea 8
PH - Filippine 8
RO - Romania 8
TN - Tunisia 8
BB - Barbados 7
SC - Seychelles 7
UY - Uruguay 7
OM - Oman 6
AL - Albania 5
BO - Bolivia 5
CH - Svizzera 5
MU - Mauritius 5
PR - Porto Rico 5
TH - Thailandia 5
BY - Bielorussia 4
CI - Costa d'Avorio 4
CW - ???statistics.table.value.countryCode.CW??? 4
LV - Lettonia 4
PA - Panama 4
RS - Serbia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
CM - Camerun 3
DK - Danimarca 3
GE - Georgia 3
LB - Libano 3
NO - Norvegia 3
SN - Senegal 3
AM - Armenia 2
BW - Botswana 2
DO - Repubblica Dominicana 2
GR - Grecia 2
Totale 45.090
Salva come PNG Salva come JPEG
Città #
Fairfield 3.212
Woodbridge 2.449
Ashburn 2.433
Houston 1.757
Jacksonville 1.741
Singapore 1.670
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.224
Hong Kong 1.191
Wilmington 1.113
San Jose 959
Warsaw 771
Council Bluffs 758
Princeton 692
Nanjing 637
Beijing 635
The Dalles 626
Chandler 515
Dublin 370
New York 343
Lauterbourg 303
Columbus 298
Istanbul 298
Helsinki 266
Los Angeles 261
Nanchang 256
Moscow 201
Des Moines 188
Ho Chi Minh City 184
Shenyang 167
Buffalo 164
São Paulo 154
Changsha 142
San Diego 135
Hebei 127
Hanoi 117
Tianjin 116
Milan 114
Jiaxing 112
Redondo Beach 104
Santa Clara 104
Chicago 92
Munich 80
Dallas 79
Shanghai 75
Kunming 72
San Francisco 72
Jinan 68
Toronto 67
Brescia 62
Orem 60
Phoenix 52
Hangzhou 50
Verona 50
Dearborn 49
Atlanta 47
London 47
Montreal 45
Lancaster 44
Rio de Janeiro 43
Tokyo 43
Brooklyn 39
Abuja 37
Lanzhou 37
San Mateo 37
Johannesburg 35
Kocaeli 35
Chennai 34
Guangzhou 33
Haikou 33
Boardman 32
Zhengzhou 32
Mexico City 31
North Bergen 30
Turku 30
Belo Horizonte 29
Dhaka 29
Manchester 29
Ningbo 29
Dong Ket 28
Leawood 28
Denver 27
Brasília 26
Brussels 24
Poplar 24
Augusta 23
Charlotte 23
Washington 23
Curitiba 22
Porto Alegre 22
Taizhou 22
Quito 21
Stockholm 21
Brno 20
Ankara 19
Da Nang 19
Mumbai 19
Rome 19
Tashkent 19
Totale 31.729
Salva come PNG Salva come JPEG
Nome #
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 386
Elevated intraocular pressure in patients with acromegaly 352
Ghrelin regulates proliferation and differentiation of osteoblastic cells 283
Guidelines for acromegaly management. 240
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 237
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 219
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 207
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 207
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 207
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 204
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 198
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 198
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 196
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 192
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 190
Growth hormone deficiency in treated acromegaly 190
Ambulatory blood pressure monitoring (ABPM) in normotensive patients with acromegaly effect of 24-h continous infusion of octreotide. 185
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 184
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 182
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 179
Diagnosis and treatment of acromegaly complications. 175
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 174
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 173
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 173
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 169
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 168
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 168
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 167
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 164
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 164
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 164
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 164
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 163
A consensus on criteria for cure of acromegaly. 162
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 160
Guidelines for acromegaly management: an update. 159
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 158
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 158
The management of the patient with acromegaly and headache: a still open clinical challenge. 157
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors. 157
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 157
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 156
Cardiovascular risk in aging and obesity: is there a role for GH. 156
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 155
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 155
Effects of metoclopramide on the paradoxical growth hormone response to galanin in acromegaly. 155
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 155
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 155
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 154
[Effects of acute administration of nifedipine on exercise-induced microalbuminuria in normotensive patients with type 1 diabetes]. 154
Acromegalic patients show the presence of hypertrophic remodelling of subcutaneous small resistance arteries 153
A consensus on criteria for cure acromegaly 153
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 153
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 152
Long-term Picotamide, a dual thromboxane inhibitor, decreases both the urinary excretion of thromboxane B2 (TXB2) and albumin in patients with type 2 diabetes. 151
Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis. 151
Growth hormone deficiency in the adult. 151
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 151
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 151
High prevalence of radiological vertebral fractures in HIV-infected males 150
New understanding and treatments for osteoporosis. 150
Preliminary observations on the effects of acute infusion of growth hormone on coronary vasculature and on myocardial function and energetics of an isolated and blood-perfused heart. 148
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 148
Pituitary testing: a reappraisal. 148
Prevalence of vertebral fractures in men with acromegaly 147
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 147
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 147
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 147
Leptin stimulates growth hormone secretion via a direct pituitary effect combined with a decreased somatostatin tone in a median eminence-pituitary perifusion study. 146
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 146
Growth hormone in glucocorticoid-induced osteoporosis. 146
Expert consensus document:A consensus on the medical treatment of acromegaly 146
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 146
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 145
Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects. 145
Octreotide for acromegaly treatment: a reappraisal. 145
Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH-an update. 144
Ambulatory blood pressure monitoring in normotensive acromegalic patients, effect of a 24 hour continuous infusion of octreotide. 143
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index. 143
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 143
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 143
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 143
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 142
New oral anticoagulants and pituitary apoplexy 142
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 141
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 141
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 141
Mechanism of action of hexarelin and GHRP-6: analysis of the involvement of GHRH and somatostatin in the rat. 141
Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency 141
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 140
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 139
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 139
Hypertrophic remodeling of subcutaneous small resistance arteries in acromegalic patients 138
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. 138
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 138
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 138
[A case of fibroangioma of the spermatic cord]. 138
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 138
Functional effects of nitric oxide-releasing aspirin on vein conduits of diabetic patients undergoing CABG. 137
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group. 137
Totale 16.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.386
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.654 0 0 0 0 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20254.411 15 14 18 605 577 376 316 97 531 262 1.003 597
2025/20268.971 991 1.283 686 1.460 874 534 1.405 302 458 623 254 101
2026/20273.455 496 510 769 1.557 123 0 0 0 0 0 0 0
Totale 45.411